MedPath

Trained Immunity in Fungal Infection and Its Mechanism

Registration Number
NCT06628544
Lead Sponsor
Zhongnan Hospital
Brief Summary

Investigator vaccinated 76 healthy BCG-naive participant with BCG, while 3 participants received. Half of BCG-vaccinated participants (n = 38) received an incremental dose of metformin for 6 days (up to 1,000 mg twice daily on day 6). On the day 0 (total 20; n = 10 for BCG vaccination, n = 10 for BCG vaccination plus taking metformin), day 14 (total 30; n=15 for BCG vaccination, n = 15 for BCG vaccination plus taking metformin), day 90 (total 26; n = 13 for BCG vaccination, n=13 for BCG vaccination plus taking metformin) of BCG vaccination, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
79
Inclusion Criteria
  • Healthy BCG-naive participants.
  • The ages range from 20 to 45.
  • Participants without any infections or immune deficiencies.
Exclusion Criteria
  • Participants when infections or other illnesses occurred during the clinical trial.
  • Participants who have a fever of unknown causes during the clinical trial.
  • Participants who have gotten other vaccines during the clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BCG vaccination with taking metformin on the day 9Metformin is administered on the day 9-
BCG vaccination without metforminBCG vaccination-
BCG vaccination with taking metformin on the day 85BCG vaccination-
BCG vaccination with taking metformin on the day 85Metformin is administered on the day 85-
PlaceboPlacebo-
BCG vaccination with taking metformin on the day 0BCG vaccination-
BCG vaccination with taking metformin on the day 0Metformin is administered on the day 0-
BCG vaccination with taking metformin on the day 9BCG vaccination-
Primary Outcome Measures
NameTimeMethod
The level of IL-6Five days of continuous medication+24 hours restimulation of C.albicans or Mycobacterium tuberculosis

After 5 days of continuous medication, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis. And the level of cytokines were determined by Elisa.

The level of TGF-alphaFive days of continuous medication+24 hours restimulation of C.albicans or Mycobacterium tuberculosis

After 5 days of continuous medication, PBMCs were isolated, restimulated with C. albicans or Mycobacterium tuberculosis. And the level of cytokines were determined by Elisa.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wuhan University

🇨🇳

Wuhan, Hubei, China, China

© Copyright 2025. All Rights Reserved by MedPath